Targeting anticancer drugs with pluronic aggregates: Recent updates

Area of Science:

• Polymer Chemistry
• Materials Science
• Nanotechnology

Background:

• Pluronics are amphiphilic triblock copolymers (PEO-PPO-PEO) that self-assemble into micelles in aqueous solutions.
• Their aggregation behavior is sensitive to molecular characteristics, temperature, and additives, leading to structures like liquid crystals and gels.
• FDA-approved Pluronics are used as injectable pharmaceutical excipients, with ongoing research into advanced applications.

Purpose of the Study:

• To review the physicochemical and design aspects of pluronic micelles for targeted cancer drug delivery.
• To explore how modifications enhance the targeting and elimination of cancerous cells.
• To discuss strategies for improving therapeutic outcomes by facilitating carrier translocation to cytosolic targets.

Main Methods:

• Literature review of physicochemical properties and design strategies for pluronic micelles.
• Analysis of chemical modifications for targeted cancer therapy.
• Discussion of translocation mechanisms from tumor interstitium to intracellular targets.

Main Results:

• Pluronic micelles exhibit tunable self-assembly and can be chemically modified for targeted drug delivery.
• Modifications, particularly on the hydrophilic block, enable specific cancer cell identification and elimination.
• Strategies exist to enhance carrier translocation for improved therapeutic efficacy.

Conclusions:

• Pluronic micelles are versatile nanocarriers for targeted cancer drug delivery.
• Chemical modifications and optimized design are crucial for effective cancer cell targeting and therapeutic enhancement.
• Further research into intracellular translocation mechanisms can optimize treatment outcomes.